Subscribe to Newsletter

Peter Karth

The Power List 2017


Peter Karth

Physician at Oregon Eye Consultants and Adjunct assistant clinical professor, Stanford UNIVERSITY, CA, USA

In addition to patient care, Karth is active in health tech, teleophthalmology, AI, and medical devices. He is a co-founder of a medical device/health tech start-up and also consults for Silicon Valley’s most prestigious tech firms, including Google and Apple. A regular contributor to many popular and peer-reviewed publications who presents at national and international events, Karth is also one of ophthalmology’s most active proponents of physicians in social media.

A nominator said: “Peter is tremendously dedicated to finding novel solutions to issues in the field of ophthalmology – I worked with him on developing a novel mobile app for vision testing and monitoring, which proactively detects the progression of retinal diseases. His dedication and contributions to the technological advances in this field, both with his work in industry and academia, make him a clear rising star 
in ophthalmology.”


Part of the Power List 2017

Top 50 rising stars

Thanks to the demographics of the developed world, the future of eyecare looks like it will be one of limited resources and rising patient burden.

So who will lead ophthalmology over the next few decades and shape its future? To find out, we asked you, our readers, to vote for ophthalmology’s Top 50 rising stars… and here they are.

Welcome to the 2017 Power List.

In 2018, The Ophthalmologist will be recognising the Top 100 pioneers and game-changers in the field of ophthalmology.

Go to The Power List 2017

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: